Real-world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi-institutional case series.

Kimberley Youkhana Glaivy BatsuliSuchitra AcharyaOsman KhanDuc Quang TranAndrea DvorakMichael RechtGuy Aaron Young Robert F Sidonio Yasmina Abajas

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2024)

In this case series, eptacog beta was safe, effective, and economical as first-line therapy, treatment of refractory BEs, management of perioperative bleeding, or prophylaxis in haemophilia patients with inhibitors.

Keyphrases

randomized controlled trial
systematic review
cardiac surgery
patients undergoing
atrial fibrillation
stem cells
replacement therapy
cell therapy
smoking cessation